☆ 4.7 Editorial Material

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Get Full Text
Add to Collection

Journal

JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume 8, Issue 1, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jitc-2020-000878

Keywords

immunomodulation; inflammation mediators

Categories

Oncology Immunology

Funding

  1. NCI NIH HHS [R35 CA197078] Funding Source: Medline
  2. NIEHS NIH HHS [P30 ES005605] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.